Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Alpha/beta interferon is a neuronal growth factor.
National MS Society: Patient Management, Care and Rehabilitation Research Grants
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
JC polyomavirus mutants escape antibody-mediated neutralization.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
Betaseron (Interferon Beta-1b) for SC Injection
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Pages
« first
‹ previous
…
65
66
67
68
69
70
71
72
73
…
next ›
last »